about
Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancerAdjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyDiagnosis and management of pancreatic cancer.Pancreatic adenocarcinomaOrthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma.Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic CancerCurrent state of adjuvant therapy in resected pancreatic adenocarcinoma.Neoadjuvant therapy in pancreatic cancer.Adjuvant therapy in pancreatic cancer: a critical appraisal.Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinomaThe influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma.Survival benefits from postoperative radiation therapy on lymph node positive patients with pancreatic adenocarcinomaRadiotherapy quality assurance report from children's oncology group AHOD0031Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity.Adjuvant treatment.Adjuvant therapy of pancreatic cancer.Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy.Pancreatic Cancer
P2860
Q24194621-C5355E5C-6DA9-44D8-8298-C184BF34560CQ33735469-73E5579B-D257-47A5-A738-734C4D15721EQ33759924-1AD823E0-20A9-4B70-A4FD-8CA643778294Q34140498-02962455-7E7B-4E35-B15B-7C02CD97F99DQ34331762-4825D08B-54B7-49DB-9B45-1A0ACF315FD5Q36058855-51707B68-D356-499B-9EAB-1771D90245FCQ36425150-DB57B0AA-4F96-492B-AD06-BD5F95EF1085Q36871043-FCEEE18C-43B9-4B3A-BF9E-8FE3EE2C1FF0Q36993370-5218EEF5-6721-431C-8DF1-9B9A5C44B0F9Q37254976-8823B4D3-9673-48E8-AC56-67FDB8CA14F1Q37522823-DCB82153-0A5F-4AA6-B038-94CFC3CF52E8Q37564830-BE05C487-37B5-4A19-B994-B0A5A4164BF3Q37590108-7CBD3E87-1ADB-4BE1-9996-64CC3EADC029Q38087989-69CD7C61-A66E-48CA-82D7-E758FE3B25E6Q41828307-68F14F5E-297A-449C-81EA-8F8DFF17F2F9Q43096597-432AAA2B-207F-4BFA-904B-38B4FD5E1732Q51170796-028CF8D8-88A1-4744-8D90-0E65E4A2DACAQ54135367-9111351B-824F-40C0-81D0-8808BE412D0F
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A challenge to the therapeutic nihilism of ESPAC-1.
@en
A challenge to the therapeutic nihilism of ESPAC-1.
@nl
type
label
A challenge to the therapeutic nihilism of ESPAC-1.
@en
A challenge to the therapeutic nihilism of ESPAC-1.
@nl
prefLabel
A challenge to the therapeutic nihilism of ESPAC-1.
@en
A challenge to the therapeutic nihilism of ESPAC-1.
@nl
P2093
P1476
A challenge to the therapeutic nihilism of ESPAC-1.
@en
P2093
Charles R Thomas
Christopher G Willett
Jerome C Landry
John P Hoffman
Mary C Koshy
Ross A Abrams
Sean X Cavanaugh
P304
P356
10.1016/J.IJROBP.2004.11.018
P407
P577
2005-03-01T00:00:00Z